PUB - Publikationen an der Universität Bielefeld

Alle markieren

• [9]
  

  2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2987695

  Krug, D.; Vladimirova, V.; Untch, M.; Kühn, T.; Schneeweiss, A.; Denkert, C.; Ataseven, B.; Solbach, C.; Gerber, B.; Tesch, H.; Golatta, M.; Seiler, S.; Heil, J.; Nekljudova, V.; Holtschmidt, J.; Loibl, S. (2024): Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy Breast ,74

  PUB | DOI | PubMed | Europe PMC
   
• [8]
  

  2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987540

  Herold, N.; Schmolling, J.; Ernst, C.; Ataseven, B.; Bluemcke, B.; Schoemig-Markiefka, B.; Heikaus, S.; Goehring, U. - J.; Engel, C.; Lampe, B.; Rhiem, K.; Harter, P.; Hauke, J.; Schmutzler, R. K.; Hahnen, E. (2024): Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. In: Abstracts from the 56th European Society of Human Genetics (ESHG) Conference. London: Nature. (European Journal of Human Genetics , 32). S. 548.

  PUB | WoS
   
• [7]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2979534

  Imterat, M.; Harter, P.; Rhiem, K.; Heitz, F.; Schneider, S.; Concin, N.; Moubarak, M.; Welz, J.; Vrentas, V.; Traut, A.; Hahnen, E.; Schmutzler, R.; du Bois, A.; Ataseven, B. (2023): Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients Cancers,15:(9):2534

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [6]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2985382

  Slomovitz, B. M.; Raaschou-Jensen, N.; Coleman, R. L.; Gilbert, L.; Powell, M. A.; Cibula, D.; Ghamande, S.; Zavallone, L.; Mendivil, A. A.; Ataseven, B.; Black, D.; Wymenga, M.; Billingsley, C.; Willmott, L. J.; McCourt, C.; Podzielinski, I.; Doehring, O.; Garside, J.; Herzog, T. J.; Mirza, M. R. (2023): PFS2 and adjustment of overall survival (OS) for subsequent anticancer therapy in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab plus chemotherapy or chemotherapy alone in the ENGOT-EN3-NSGO/GOG-3031/RUBY trial. In: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023. Amsterdam: Elsevier. ( Annals of Oncology , 34). S. S514-S515.

  PUB | DOI | WoS
   
• [5]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984317

  Marme, F.; Krieghoff-Henning, E.; Gerber, B.; Schmitt, M.; Zahm, D. - M.; Bauerschlag, D.; Forstbauer, H.; Hildebrandt, G.; Ataseven, B.; Brodkorb, T.; Denkert, C.; Stachs, A.; Krug, D.; Heil, J.; Golatta, M.; Kühn, T.; Nekljudova, V.; Gaiser, T.; Schönmehl, R.; Brochhausen, C.; Loibl, S.; Reimer, T.; Brinker, T. J. (2023): Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images European Journal of Cancer,195:113390

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [4]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984002

  Imterat, M.; Gebers, G.; Heitz, F.; Schneider, S.; Ehmann, S.; Welz, J.; du Bois, A.; Traut, A.; Walz, M. K.; Concin, N.; Harter, P.; Ataseven, B. (2023): Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study Gynecologic Oncology,178: 96-101.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [3]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984318

  Bizzarri, N.; Imterat, M.; Fruscio, R.; Giannarelli, D.; Perrone, A. M.; Mancari, R.; Traut, A.; Rosati, A.; du Bois, A.; Ferrari, D.; De Iaco, P.; Ergasti, R.; Ataseven, B.; Bianchi, T.; Di Stanislao, M.; Perri, M. T.; Heitz, F.; Concin, N.; Fanfani, F.; Vizza, E.; Scambia, G.; Harter, P.; Fagotti, A. (2023): Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth? European Journal of Cancer,195:113398

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [2]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2980959

  Herold, N.; Schmolling, J.; Ernst, C.; Ataseven, B.; Blümcke, B.; Schömig-Markiefka, B.; Heikaus, S.; Göhring, U. - J.; Engel, C.; Lampe, B.; Rhiem, K.; Harter, P.; Hauke, J.; Schmutzler, R. K.; Hahnen, E. (2023): Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer Cancer Medicine

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [1]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2979540

  Inci, M. G.; Sehouli, J.; Schnura, E.; Lee, M.; Roll, S.; Reinhold, T.; Klews, J.; Kaufner, L.; Niggemann, P.; Groeben, H.; Toelkes, J.; Reisshauer, A.; Liebl, M.; Daehnert, E.; Zimmermann, M.; Knappe-Drzikova, B.; Rolker, S.; Nunier, B.; Algharably, E.; Pirmorady Sehouli, A.; Zwantleitner, L.; Krull, A.; Heitz, F.; Ataseven, B.; Chekerov, R.; Harter, P.; Schneider, S. (2023): The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design International Journal of Gynecological Cancer ,ijgc-2023-004531

  PUB | DOI | WoS | PubMed | Europe PMC